2020-10635. COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry; Availability  

Document Information

Published:
05/19/2020
Department:
Health and Human Services Department
Agency:
Food and Drug Administration
EntryType:
Notice
Action:
Notice of availability.
Document Number:
2020-10635
Dates:
The announcement of the guidance is published in the Federal Register on May 19, 2020. The guidance document is immediately in effect, but it remains subject to comment in accordance with the Agency's good guidance practices.
Pages:
29949-29951 (3 pages)
Docket Numbers:
Docket No. FDA-2020-D-1370
SectionNoes:
PDF File:
2020-10635.pdf